The DOI matches its Crossref record; 233 of the 233 references it cites were found in a registry or an index.
Endothelial dysfunction — A major mediator of diabetic vascular disease
Open accessAbstract
The vascular endothelium is a multifunctional organ and is critically involved in modulating vascular tone and structure. Endothelial cells produce a wide range of factors that also regulate cellular adhesion, thromboresistance, smooth muscle cell proliferation, and vessel wall inflammation. Thus, endothelial function is important for the homeostasis of the body and its dysfunction is associated with several pathophysiological conditions, including atherosclerosis, hypertension and diabetes. Patients with diabetes invariably show an impairment of endothelium-dependent vasodilation. Therefore, understanding and treating endothelial dysfunction is a major focus in the prevention of vascular complications associated with all forms of diabetes mellitus. The mechanisms of endothelial dysfunction in diabetes may point to new management strategies for the prevention of cardiovascular disease in diabetes. This review will focus on the mechanisms and therapeutics that specifically target endothelial dysfunction in the context of a diabetic setting. Mechanisms including altered glucose metabolism, impaired insulin signaling, low-grade inflammatory state, and increased reactive oxygen species generation will be discussed. The importance of developing new pharmacological approaches that upregulate endothelium-derived nitric oxide synthesis and target key vascular ROS-producing enzymes will be highlighted and new strategies that might prove clinically relevant in preventing the development and/or retarding the progression of diabetes associated vascular complications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Wang, S., Xu, J. C., Song, P., Viollet, B., & Zou, M. (2009) · Diabetes · doi:10.2337/db09-0267 · Cited by 142
Retracted(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
A novel potent vasoconstrictor peptide produced by vascular endothelial cells
Yanagisawa, M., Kurihara, H., Kimura, S., Tomobe, Y., Kobayashi, M., Mitsui, Y., Yazaki, Y., Goto, K., & Masaki, T. (1988) · Nature · doi:10.1038/332411a0 · Cited by 10,729
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704 · cited 1×
“Endothelium-derived factors with vasodilatory and antiproliferative effects include, endothelium-derived hyperpolarisation factor (EDHF) [6,7], nitric oxide (NO) [8,9] and”
BackgroundBiochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Hydroperoxide metabolism in mammalian organs.
Chance, B., Sies, H., & Boveris, A. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.3.527 · Cited by 5,827
Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., Grassi, G., Heagerty, A. M., Kjeldsen, S. E., Laurent, S., et al. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3281fc975a · Cited by 5,824
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Mitochondrial formation of reactive oxygen species
Turrens, J. F. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049478 · Cited by 5,084
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage
Nishikawa, T., Edelstein, D., Du, X. L., Yamagishi, S.-I., Matsumura, T., Kaneda, Y., Yorek, M. A., Beebe, D., Oates, P. J., Hammes, H.-P., et al. (2000) · Nature · doi:10.1038/35008121 · Cited by 4,277
Pathobiology of ischaemic stroke: an integrated view
Dirnagl, U., Iadecola, C., & Moskowitz, M. A. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01401-0 · Cited by 3,943
Glutathione Metabolism and Its Implications for Health
Wu, G., Lupton, J. R., Turner, N. D., Fang, Y.-Z., & Yang, S. (2004) · The Journal of Nutrition · doi:10.1093/jn/134.3.489 · Cited by 3,842
Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress
Cai, H., & Harrison, D. G. (2000) · Circulation Research · doi:10.1161/01.res.87.10.840 · Cited by 3,839
Banting lecture 1988. Role of insulin resistance in human disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diabetes.37.12.1595 · Cited by 3,811
Moncada, S., Gryglewski, R., Bunting, S., & Vane, J. R. (1976) · Nature · doi:10.1038/263663a0 · Cited by 3,595
Hayes, J. D., Flanagan, J. U., & Jowsey, I. R. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095857 · Cited by 3,544
Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management
Beckman, J. A., Creager, M. A., & Libby, P. (2002) · JAMA · doi:10.1001/jama.287.19.2570 · Cited by 2,724
Advanced Glycation End Products: Sparking the Development of Diabetic Vascular Injury
Goldin, A., Beckman, J. A., Schmidt, A. M., & Creager, M. A. (2006) · Circulation · doi:10.1161/circulationaha.106.621854 · Cited by 2,261
Zelko, I. N., Mariani, T. J., & Folz, R. J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00905-x · Cited by 2,212
Endothelial Dysfunction: A Marker of Atherosclerotic Risk
Bonetti, P. O., Lerman, L. O., & Lerman, A. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000051384.43104.fc · Cited by 2,200
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Polyphenols and disease risk in epidemiologic studies
Arts, I. C., & Hollman, P. C. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.317s · Cited by 1,916 · cited 1×
“) and the incidence of cardiovascular disease [203-205].”
BackgroundKim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part I
Creager, M. A., Lüscher, T. F., of, P. W. T. A., Cosentino, F., & Beckman, J. A. (2003) · Circulation · doi:10.1161/01.cir.0000091257.27563.32 · Cited by 1,650
Joannides, R., Haefeli, W. E., Linder, L., Richard, V., Bakkali, E. H., Thuillez, C., & Lüscher, T. F. (1995) · Circulation · doi:10.1161/01.cir.91.5.1314 · Cited by 1,622
Inoguchi, T., Li, P., Umeda, F., Yu, H. Y., Kakimoto, M., Imamura, M., Aoki, T., Etoh, T., Hashimoto, T., Naruse, M., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.11.1939 · Cited by 1,577
Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors
Vásquez-Vivar, J., Kalyanaraman, B., Martásek, P., Hogg, N., Masters, B. S. S., Karoui, H., Tordo, P., & Pritchard, K. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9220 · Cited by 1,484
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
Role of oxidative stress in atherosclerosis
Harrison, D., Griendling, K. K., Landmesser, U., Hornig, B., & Drexler, H. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03144-2 · Cited by 1,275
Endemann, D. H., & Schiffrin, E. L. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000132474.50966.da · Cited by 1,198
Aviram, M., Rosenblat, M., Bisgaier, C. L., Newton, R. S., Primo-Parmo, S. L., & La Du, B. N. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1649 · Cited by 1,168
Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
Cade, W. T. (2008) · Physical Therapy · doi:10.2522/ptj.20080008 · Cited by 1,084
Dietary polyphenols and their biological significance
Han, X., Shen, T., & Lou, H. (2007) · International Journal of Molecular Sciences · doi:10.3390/i8090950 · Cited by 1,081 · cited 1×
“Resveratrol benefits the circulatory system by eliciting a decrease in the oxidation of LDL; by fostering decreases in platelet aggregation; and by promoting relaxation of arterioles [213].”
BackgroundMice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis
Shih, D. M., Gu, L., Xia, Y.-R., Navab, M., Li, W.-F., Hama, S., Castellani, L. W., Furlong, C. E., Costa, L. G., Fogelman, A. M., et al. (1998) · Nature · doi:10.1038/28406 · Cited by 1,078
Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE
Wautier, M.-P., Chappey, O., Corda, S., Stern, D. M., Schmidt, A. M., & Wautier, J.-L. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.5.e685 · Cited by 1,072
Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide.
Boulanger, C., & Lüscher, T. F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114477 · Cited by 1,045
The Role of Advanced Glycation End Products in Progression and Complications of Diabetes
Goh, S.-Y., & Cooper, M. E. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1817 · Cited by 987
Guzik, T. J., Mussa, S., Gastaldi, D., Sadowski, J., Ratnatunga, C., Pillai, R., & Channon, K. M. (2002) · Circulation · doi:10.1161/01.cir.0000012748.58444.08 · Cited by 979
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3403 · Cited by 899
Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Diabetes Care · doi:10.2337/dc08-9026 · Cited by 881
Cardiovascular Actions of Insulin
Muniyappa, R., Montagnani, M., Koh, K. K., & Quon, M. J. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0006 · Cited by 872
Oxygen Toxicity: A Radical Explanation
Fridovich, I. (1998) · Journal of Experimental Biology · doi:10.1242/jeb.201.8.1203 · Cited by 857
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818 · cited 8×
“Functional impairment of the vascular endothelium is found in all forms of cardiovascular disease [3, 12] and also in people with insulin resistance, obesity and type 2 diabetes [18].”
BackgroundInfluentialSchmidt, A. M., Yan, S. D., Wautier, J.-L., & Stern, D. (1999) · Circulation Research · doi:10.1161/01.res.84.5.489 · Cited by 791
Endothelium‐dependent hyperpolarization of canine coronary smooth muscle
Feletou, M., & Vanhoutte, P. M. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb10306.x · Cited by 776
Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology
Li, J.-M., & Shah, A. M. (2004) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00124.2004 · Cited by 773
Kojda, G. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00169-8 · Cited by 768
Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation
Steinberg, H. O., Tarshoby, M., Monestel, R., Hook, G., Cronin, J., Johnson, A., Bayazeed, B., & Baron, A. D. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119636 · Cited by 761
Mitochondria in homeostasis of reactive oxygen species in cell, tissues, and organism
Ježek, P., & Hlavatá, L. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2005.05.013 · Cited by 744
Acetylcholine releases endothelium‐derived hyperpolarizing factor and EDRF from rat blood vessels
Chen, G., Suzuki, H., & Weston, A. H. (1988) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1988.tb11752.x · Cited by 688
Shimokawa, H., Yasutake, H., Fujii, K., Owada, M. K., Nakaike, R., Fukumoto, Y., Takayanagi, T., Nagao, T., Egashira, K., Fujishima, M., et al. (1996) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199611000-00014 · Cited by 679
Stolk, J., Hiltermann, T. J., Dijkman, J. H., & Verhoeven, A. J. (1994) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.11.1.8018341 · Cited by 648
Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase
Schröder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J., Kruse, C., Luedike, P., Michaelis, U. R., Weissmann, N., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.267054 · Cited by 622
De Keulenaer, G. W., Chappell, D. C., Ishizaka, N., Nerem, R. M., Alexander, R. W., & Griendling, K. K. (1998) · Circulation Research · doi:10.1161/01.res.82.10.1094 · Cited by 612
Diabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activation
Garcia Soriano, F., Virág, L., Jagtap, P., Szabó, É., Mabley, J. G., Liaudet, L., Marton, A., Hoyt, D. G., Murthy, K. G. K., Salzman, A. L., et al. (2001) · Nature Medicine · doi:10.1038/83241 · Cited by 603
S-glutathionylation uncouples eNOS and regulates its cellular and vascular function
Chen, C.-A., Wang, T.-Y., Varadharaj, S., Reyes, L. A., Hemann, C., Talukder, M. A. H., Chen, Y.-R., Druhan, L. J., & Zweier, J. L. (2010) · Nature · doi:10.1038/nature09599 · Cited by 594
NADPH Oxidases: Functions and Pathologies in the Vasculature
Lassègue, B., & Griendling, K. K. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.181610 · Cited by 592
Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine
Valkonen, V.-P., Päivä, H., Salonen, J. T., Lakka, T. A., Lehtimäki, T., Laakso, J., & Laaksonen, R. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07184-7 · Cited by 562
Molecular aspects of lipoic acid in the prevention of diabetes complications
Packer, L., Kraemer, K., & Rimbach, G. (2001) · Nutrition · doi:10.1016/s0899-9007(01)00658-x · Cited by 556
Role of insulin resistance in endothelial dysfunction
Muniyappa, R., & Sowers, J. R. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-012-9229-1 · Cited by 539
Duplain, H., Burcelin, R., Sartori, C., Cook, S., Egli, M., Lepori, M., Vollenweider, P., Pedrazzini, T., Nicod, P., Thorens, B., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.342 · Cited by 533
Boden, G., She, P., Mozzoli, M., Cheung, P., Gumireddy, K., Reddy, P., Xiang, X., Luo, Z., & Ruderman, N. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3458 · Cited by 528
Heme oxygenase-1 protects against vascular constriction and proliferation
Duckers, H. J., Boehm, M., True, A. L., Yet, S.-F., San, H., Park, J. L., Clinton Webb, R., Lee, M.-E., Nabel, G. J., & Nabel, E. G. (2001) · Nature Medicine · doi:10.1038/89068 · Cited by 525
Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease
Versari, D., Daghini, E., Virdis, A., Ghiadoni, L., & Taddei, S. (2009) · Diabetes Care · doi:10.2337/dc09-s330 · Cited by 516
Behrendt, D., & Ganz, P. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02963-6 · Cited by 499
Polyphenols and cardiovascular disease: effects on endothelial and platelet function
Vita, J. A. (2005) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/81.1.292s · Cited by 498
Endothelium-Derived Hyperpolarizing Factor: Where Are We Now?
Félétou, M., & Vanhoutte, P. M. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000217611.81085.c5 · Cited by 488
Impaired free fatty acid utilization by skeletal muscle in non-insulin-dependent diabetes mellitus.
Kelley, D. E., & Simoneau, J. A. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117600 · Cited by 487
Oxidation of Tetrahydrobiopterin by Peroxynitrite: Implications for Vascular Endothelial Function
Milstien, S., & Katusic, Z. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1422 · Cited by 486
Aviram, M., Hardak, E., Vaya, J., Mahmood, S., Milo, S., Hoffman, A., Billicke, S., Draganov, D., & Rosenblat, M. (2000) · Circulation · doi:10.1161/01.cir.101.21.2510 · Cited by 460
Dysfunction of Endothelial Nitric Oxide Synthase and Atherosclerosis
Kawashima, S., & Yokoyama, M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000125114.88079.96 · Cited by 453
de Haan, J. B., Bladier, C., Griffiths, P., Kelner, M., O'Shea, R. D., Cheung, N. S., Bronson, R. T., Silvestro, M. J., Wild, S., Zheng, S. S., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22528 · Cited by 450
Fleming, I., Michaelis, U. R., Bredenkötter, D., Fisslthaler, B., Dehghani, F., Brandes, R. P., & Busse, R. (2001) · Circulation Research · doi:10.1161/01.res.88.1.44 · Cited by 440
Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension
Schulz, E., Jansen, T., Wenzel, P., Daiber, A., & Münzel, T. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1989 · Cited by 430
Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective Study
Mackness, B., Durrington, P., McElduff, P., Yarnell, J., Azam, N., Watt, M., & Mackness, M. (2003) · Circulation · doi:10.1161/01.cir.0000070954.00271.13 · Cited by 421
Nitric Oxide and the Vascular Endothelium
Moncada, S., & Higgs, E. A. (2006) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-32967-6_7 · Cited by 408
Angiotensin II Signaling in Vascular Smooth Muscle: New Concepts
Griendling, K. K., Ushio-Fukai, M., Lassègue, B., & Alexander, R. W. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.366 · Cited by 407
Mitochondrial dysfunction in cardiovascular disease
Ballinger, S. W. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.02.014 · Cited by 405 · cited 2×
“16 allowing ROS to exert their deleterious effects and ultimately change mitochondrial function [117,132,136].”
BackgroundReduced Endothelial Nitric Oxide Synthase Expression and Production in Human Atherosclerosis
Oemar, B. S., Tschudi, M. R., Godoy, N., Brovkovich, V., Malinski, T., & Lüscher, T. F. (1998) · Circulation · doi:10.1161/01.cir.97.25.2494 · Cited by 396
Endothelial function and nitric oxide: clinical relevance
Vallance, P., & Chan, N. (2001) · Heart · doi:10.1136/heart.85.3.342 · Cited by 388
NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis
Gray, S. P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A. C., de Haan, J. B., Koulis, C., El-Osta, A., Andrews, K. L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.132159 · Cited by 386
Insulin signal transduction through protein kinase cascades
Avruch, J. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006823109415 · Cited by 365
Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease
Corral-Debrinski, M., Shoffner, J. M., Lott, M. T., & Wallace, D. C. (1992) · Mutation Research/DNAging · doi:10.1016/0921-8734(92)90021-g · Cited by 364
Molecular Insights and Therapeutic Targets for Diabetic Endothelial Dysfunction
Xu, J., & Zou, M.-H. (2009) · Circulation · doi:10.1161/circulationaha.108.835223 · Cited by 353
Skyler, J. S., Bergenstal, R., Bonow, R. O., Buse, J., Deedwania, P., Gale, E. A. M., Howard, B. V., Kirkman, M. S., Kosiborod, M., Reaven, P., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.191305 · Cited by 348
Du, X., Edelstein, D., Obici, S., Higham, N., Zou, & Brownlee, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci23354 · Cited by 347
Suzuki, H., Swei, A., Zweifach, B. W., & Schmid-Schönbein, G. W. (1995) · Hypertension · doi:10.1161/01.hyp.25.5.1083 · Cited by 340
From excess adiposity to insulin resistance: The role of free fatty acids
Capurso, C., & Capurso, A. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.05.003 · Cited by 337
Laughlin, M. H., Newcomer, S. C., & Bender, S. B. (2008) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01096.2007 · Cited by 336
Gao, Z., Zhang, X., Zuberi, A., Hwang, D., Quon, M. J., Lefevre, M., & Ye, J. (2004) · Molecular Endocrinology · doi:10.1210/me.2003-0383 · Cited by 335
Juan, S.-H., Lee, T.-S., Tseng, K.-W., Liou, J.-Y., Shyue, S.-K., Wu, K. K., & Chau, L.-Y. (2001) · Circulation · doi:10.1161/hc3801.095663 · Cited by 331
Shinozaki, K., Kashiwagi, A., Nishio, Y., Okamura, T., Yoshida, Y., Masada, M., Toda, N., & Kikkawa, R. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2437 · Cited by 329
Wolfrum, S., Dendorfer, A., Rikitake, Y., Stalker, T. J., Gong, Y., Scalia, R., Dominiak, P., & Liao, J. K. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000142813.33538.82 · Cited by 328
Rosenblat, M., Hayek, T., & Aviram, M. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.09.006 · Cited by 319
Pacher, P., & Szabó, C. (2007) · Cardiovascular Drug Reviews · doi:10.1111/j.1527-3466.2007.00018.x · Cited by 316
Adropin Is a Novel Regulator of Endothelial Function
Lovren, F., Pan, Y., Quan, A., Singh, K. K., Shukla, P. C., Gupta, M., Al-Omran, M., Teoh, H., & Verma, S. (2010) · Circulation · doi:10.1161/circulationaha.109.931782 · Cited by 316
Free Fatty Acid Impairment of Nitric Oxide Production in Endothelial Cells Is Mediated by IKKβ
Kim, F., Tysseling, K. A., Rice, J., Pham, M., Haji, L., Gallis, B. M., Baas, A. S., Paramsothy, P., Giachelli, C. M., Corson, M. A., et al. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000160549.60980.a8 · Cited by 307
Pathophysiological implications of insulin resistance on vascular endothelial function
Wheatcroft, S. B., Williams, I. L., Shah, A. M., & Kearney, M. T. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00869.x · Cited by 306
Vincent, M. A., Barrett, E. J., Lindner, J. R., Clark, M. G., & Rattigan, S. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00021.2003 · Cited by 305
Endothelial Function and Oxidant Stress
Harrison, D. G. (1997) · Clinical Cardiology · doi:10.1002/j.1932-8737.1997.tb00007.x · Cited by 304
RAGE (receptor for advanced glycation end products): a central player in the inflammatory response
Chavakis, T., Bierhaus, A., & Nawroth, P. P. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.08.004 · Cited by 301
The paraoxonase gene family and atherosclerosis
Ng, C. J., Shih, D. M., Hama, S. Y., Villa, N., Navab, M., & Reddy, S. T. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.09.035 · Cited by 292
Mitochondria and Reactive Oxygen Species
Addabbo, F., Montagnani, M., & Goligorsky, M. S. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.130054 · Cited by 286
Metabolism of oxygen radicals in peroxisomes and cellular implications
del Río, L. A., Sandalio, L. M., Palma, J., Bueno, P., & Corpas, F. J. (1992) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(92)90150-f · Cited by 285
Quehenberger, P., Bierhaus, A., Fasching, P., Muellner, C., Klevesath, M., Hong, M., Stier, G., Sattler, M., Schleicher, E., Speiser, W., et al. (2000) · Diabetes · doi:10.2337/diabetes.49.9.1561 · Cited by 283
Sola, S., Mir, M. Q. S., Cheema, F. A., Khan-Merchant, N., Menon, R. G., Parthasarathy, S., & Khan, B. V. (2005) · Circulation · doi:10.1161/01.cir.0000153272.48711.b9 · Cited by 282
Endothelial Dysfunction in Diabetes: From Mechanisms to Therapeutic Targets
Potenza, M., Gagliardi, S., Nacci, C., Carratu, M., & Montagnani, M. (2009) · Current Medicinal Chemistry · doi:10.2174/092986709787002853 · Cited by 280
NADPH oxidase and endothelial cell function
Ray, R., & Shah, A. M. (2005) · Clinical Science · doi:10.1042/cs20050067 · Cited by 279
Wong, R. H. X., Howe, P. R. C., Buckley, J. D., Coates, A. M., Kunz, I., & Berry, N. M. (2011) · Nutrition, Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.03.003 · Cited by 277
Zhou, S., Chen, H.-Z., Wan, Y.-Z., Zhang, Q.-J., Wei, Y.-S., Huang, S., Liu, J.-J., Lu, Y.-B., Zhang, Z.-Q., Yang, R.-F., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.243592 · Cited by 273
Habauzit, V., & Morand, C. (2012) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622311430006 · Cited by 261
Antoniades, C., Shirodaria, C., Leeson, P., Antonopoulos, A., Warrick, N., Van-Assche, T., Cunnington, C., Tousoulis, D., Pillai, R., Ratnatunga, C., et al. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp061 · Cited by 258
Interactions Between Nitric Oxide and Lipid Oxidation Pathways: Implications for Vascular Disease
O’Donnell, V. B., & Freeman, B. A. (2001) · Circulation Research · doi:10.1161/01.res.88.1.12 · Cited by 257
Lewis, P., Stefanovic, N., Pete, J., Calkin, A. C., Giunti, S., Thallas-Bonke, V., Jandeleit-Dahm, K. A., Allen, T. J., Kola, I., Cooper, M. E., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.664250 · Cited by 246
Horke, S., Witte, I., Wilgenbus, P., Krüger, M., Strand, D., & Förstermann, U. (2007) · Circulation · doi:10.1161/circulationaha.106.681700 · Cited by 246
Comparative pharmacology of chemically distinct nadph oxidase inhibitors
Wind, S., Beuerlein, K., Eucker, T., Müller, H., Scheurer, P., Armitage, M., Ho, H., Schmidt, H., & Wingler, K. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00920.x · Cited by 241
Zheng, L., Szabó, C., & Kern, T. S. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2960 · Cited by 238
Resveratrol increases vascular oxidative stress resistance
Ungvari, Z., Orosz, Z., Rivera, A., Labinskyy, N., Xiangmin, Z., Olson, S., Podlutsky, A., & Csiszar, A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01258.2006 · Cited by 237
Chakravarthy, U., Hayes, R. G., Stitt, A. W., McAuley, E., & Archer, D. B. (1998) · Diabetes · doi:10.2337/diabetes.47.6.945 · Cited by 237
Correlation between cardiovascular disease and diabetes mellitus: current concepts
Nesto, R. W. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.016 · Cited by 231
Yang, H., Roberts, L. J., Shi, M. J., Zhou, L. C., Ballard, B. R., Richardson, A., & Guo, Z. M. (2004) · Circulation Research · doi:10.1161/01.res.0000149564.49410.0d · Cited by 230
Wang, X. L., Zhang, L., Youker, K., Zhang, M.-X., Wang, J., LeMaire, S. A., Coselli, J. S., & Shen, Y. H. (2006) · Diabetes · doi:10.2337/db05-1574 · Cited by 230
Targeting NADPH oxidases in vascular pharmacology
Schramm, A., Matusik, P., Osmenda, G., & Guzik, T. J. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.02.012 · Cited by 228
Thioredoxin: A Key Regulator of Cardiovascular Homeostasis
Yamawaki, H., Haendeler, J., & Berk, B. C. (2003) · Circulation Research · doi:10.1161/01.res.0000102869.39150.23 · Cited by 227
Naruse, K., Rask-Madsen, C., Takahara, N., Ha, S.-W., Suzuma, K., Way, K. J., Jacobs, J. R. C., Clermont, A. C., Ueki, K., Ohshiro, Y., et al. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-0771 · Cited by 220
Kietadisorn, R., Juni, R. P., & Moens, A. L. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00540.2011 · Cited by 215
Methylglyoxal promotes oxidative stress and endothelial dysfunction
Sena, C. M., Matafome, P., Crisóstomo, J., Rodrigues, L., Fernandes, R., Pereira, P., & Seiça, R. M. (2012) · Pharmacological Research · doi:10.1016/j.phrs.2012.03.004 · Cited by 212
Self-citationWine Flavonoids Protect against LDL Oxidation and Atherosclerosis
AVIRAM, M., & FUHRMAN, B. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02913.x · Cited by 206
Heme Oxygenase-1: A Novel Drug Target for Atherosclerotic Diseases?
Stocker, R., & Perrella, M. A. (2006) · Circulation · doi:10.1161/circulationaha.105.598698 · Cited by 206
Heme Oxygenase and Atherosclerosis
Morita, T. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000178169.95781.49 · Cited by 206
Weiss, N., Zhang, Y.-Y., Heydrick, S., Bierl, C., & Loscalzo, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231428998 · Cited by 205
Red wine increases the expression of human endothelial nitric oxide synthase
Wallerath, T., Poleo, D., Li, H., & Förstermann, U. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02826-7 · Cited by 204
Félétou, M. (2011) · Colloquium Series on Integrated Systems Physiology: From Molecule to Function · doi:10.4199/c00031ed1v01y201105isp019 · Cited by 200
Natali, A., Toschi, E., Baldeweg, S., Ciociaro, D., Favilla, S., Saccà, L., & Ferrannini, E. (2006) · Diabetes · doi:10.2337/diabetes.55.04.06.db05-1076 · Cited by 199
Rho Kinase Inhibition by Fasudil Ameliorates Diabetes-Induced Microvascular Damage
Arita, R., Hata, Y., Nakao, S., Kita, T., Miura, M., Kawahara, S., Zandi, S., Almulki, L., Tayyari, F., Shimokawa, H., et al. (2009) · Diabetes · doi:10.2337/db08-0762 · Cited by 196
Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products
Biao, X., Chibber, R., Ruggiero, D., Kohner, E., Ritter, J., & Ferro, A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0490fje · Cited by 195
EDHF: spreading the influence of the endothelium
Garland, C. J., Hiley, C. R., & Dora, K. A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01148.x · Cited by 195
Grgic, I., Kaistha, B. P., Hoyer, J., & Köhler, R. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00132.x · Cited by 193
The NO cascade, eNOS location, and microvascular permeability
Duran, W. N., Breslin, J. W., & Sanchez, F. A. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq139 · Cited by 191
Levonen, A.-L., Inkala, M., Heikura, T., Jauhiainen, S., Jyrkkänen, H.-K., Kansanen, E., Määttä, K., Romppanen, E., Turunen, P., Rutanen, J., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000258868.80079.4d · Cited by 189
Oxidative Enzymopathies and Vascular Disease
Leopold, J. A., & Loscalzo, J. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000163846.51473.09 · Cited by 189
Torzewski, M., Ochsenhirt, V., Kleschyov, A. L., Oelze, M., Daiber, A., Li, H., Rossmann, H., Tsimikas, S., Reifenberg, K., Cheng, F., et al. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000258809.47285.07 · Cited by 186
Targeting of superoxide dismutase and catalase to vascular endothelium
Muzykantov, V. R. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00215-2 · Cited by 184
Szabó, C., Mabley, J. G., Moeller, S. M., Shimanovich, R., Pacher, P., Virág, L., Soriano, F. G., Van Duzer, J. H., Williams, W., Salzman, A. L., et al. (2002) · Molecular Medicine · doi:10.1007/bf03402167 · Cited by 175
Jové, M., Planavila, A., Sánchez, R. M., Merlos, M., Laguna, J. C., & Vázquez-Carrera, M. (2006) · Endocrinology · doi:10.1210/en.2005-0440 · Cited by 172
Metformin restores endothelial function in aorta of diabetic rats
Sena, C. M., Matafome, P., Louro, T., Nunes, E., Fernandes, R., & Seiça, R. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01230.x · Cited by 170
Self-citationNg, C. J., Bourquard, N., Grijalva, V., Hama, S., Shih, D. M., Navab, M., Fogelman, A. M., Lusis, A. J., Young, S., & Reddy, S. T. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605379200 · Cited by 165
Asymmetric Dimethylarginine Predicts Cardiovascular Events in Patients With Type 2 Diabetes
Krzyżanowska, K., Mittermayer, F., Wolzt, M., & Schernthaner, G. (2007) · Diabetes Care · doi:10.2337/dc07-0019 · Cited by 164
Oxidative Stress and Vascular Function: Implications for Pharmacologic Treatments
Weseler, A. R., & Bast, A. (2010) · Current Hypertension Reports · doi:10.1007/s11906-010-0103-9 · Cited by 163
Endothelial dysfunction and cardiovascular risk factors
Grover-Páez, F., & Zavalza-Gómez, A. B. (2009) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.12.013 · Cited by 158
Frombaum, M., Clanche, S. L., Bonnefont‐Rousselot, D., & Borderie, D. (2011) · Biochimie · doi:10.1016/j.biochi.2011.11.001 · Cited by 157
Ikeda, Y., Suehiro, T., Inoue, M., Nakauchi, Y., Morita, T., Arii, K., Ito, H., Kumon, Y., & Hashimoto, K. (1998) · Metabolism · doi:10.1016/s0026-0495(98)90246-3 · Cited by 153
Rozenberg, O., Shih, D. M., & Aviram, M. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.12.030 · Cited by 147
The link between metabolic abnormalities and endothelial dysfunction in type 2 diabetes: An update
Zhang, H., Dellsperger, K. C., & Zhang, C. (2012) · Basic Research in Cardiology · doi:10.1007/s00395-011-0237-1 · Cited by 144
Mittermayer, F., Krzyżanowska, K., Exner, M., Mlekusch, W., Amighi, J., Sabeti, S., Minar, E., Müller, M. M., Wolzt, M., & Schillinger, M. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000242801.38419.48 · Cited by 144
Taddei, S., Ghiadoni, L., Virdis, A., Versari, D., & Salvetti, A. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033453866 · Cited by 142
Emerging potential of thioredoxin and thioredoxin interacting proteins in various disease conditions
Maulik, N., & Das, D. K. (2008) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2007.12.008 · Cited by 140
Nox2 NADPH Oxidase Has a Critical Role in Insulin Resistance–Related Endothelial Cell Dysfunction
Sukumar, P., Viswambharan, H., Imrie, H., Cubbon, R. M., Yuldasheva, N. Y., Gage, M., Galloway, S. L., Skromna, A., Kandavelu, P., Santos, C. X. C., et al. (2013) · Diabetes · doi:10.2337/db12-1294 · Cited by 137
Hirose, A., Tanikawa, T., Mori, H., Okada, Y., & Tanaka, Y. (2010) · FEBS Letters · doi:10.1016/j.febslet.2009.11.082 · Cited by 129
Human obesity and endothelium‐dependent responsiveness
Campia, U., Tesauro, M., & Cardillo, C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01661.x · Cited by 127
Bernatchez, P. N., Sharma, A., Bauer, P. M., Marin, E. P., & Sessa, W. C. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44778 · Cited by 126
Insulin Action Is Associated With Endothelial Function in Hypertension and Type 2 Diabetes
Cleland, S. J., Petrie, J. R., SMALL, M. P., Elliott, H. L., & Connell, J. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.507 · Cited by 125
AMP-Activated Protein Kinase and Metabolic Control
Viollet, B., & Andréelli, F. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_13 · Cited by 121
Effects of α‐lipoic acid on endothelial function in aged diabetic and high‐fat fed rats
Sena, C. M., Nunes, E., Louro, T. M., Proença, T., Fernandes, R., Boarder, M. R., & Seiça, R. M. F. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707474 · Cited by 121
Self-citationStasch, J., Dembowsky, K., Perzborn, E., Stahl, E., & Schramm, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704483 · Cited by 120
S17834, a New Inhibitor of Cell Adhesion and Atherosclerosis That Targets NADPH Oxidase
Cayatte, A. J., Rupin, A., Oliver-Krasinski, J. M., Maitland, K. A., Sansilvestri, P., Boussard, M.-F., Wierzbicki, M., Verbeuren, T. J., & Cohen, R. A. (2001) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/hq1001.096723 · Cited by 117
Importance of asymmetrical dimethylarginine in cardiovascular risk
Vallance, P. J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)07229-4 · Cited by 116
Grassi, D., Desideri, G., Necozione, S., Ruggieri, F., Blumberg, J. B., Stornello, M., & Ferri, C. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.193995 · Cited by 113
Nanocarriers for Vascular Delivery of Antioxidants
Hood, E. D., Simone, E. A., Wattamwar, P. P., Dziubla, T. D., & Muzykantov, V. R. (2011) · Nanomedicine · doi:10.2217/nnm.11.92 · Cited by 111
Wan, J., Huang, L., Rong, R., Tan, R., Wang, J., & Kang, J. X. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.210054 · Cited by 111
Li, Q., Bolli, R., Qiu, Y., Tang, X., Murphree, S. S., & French, B. A. (1998) · Circulation · doi:10.1161/01.cir.98.14.1438 · Cited by 107
Schiano, V., Laurenzano, E., Brevetti, G., Maio, J. I. D., Lanero, S., Scopacasa, F., & Chiariello, M. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2007.11.007 · Cited by 107
Hjerkinn, E. M., Abdelnoor, M., Breivik, L., Bergengen, L., Ellingsen, I., Seljeflot, I., Aase, O., Klemsdal, T. O., Hjermann, I., & Arnesen, H. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000209817.28444.fb · Cited by 106
Soccio, M., Toniato, E., Evangelista, V., Carluccio, M. A., & Caterina, R. D. (2005) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2005.01500.x · Cited by 104
Red Blood Cell Nitric Oxide as an Endocrine Vasoregulator
Datta, B. N., Tufnell-Barret, T., Bleasdale, R. A., Jones, C. J. H., Beeton, I., Paul, V., Frenneaux, M. P., & James, P. E. (2004) · Circulation · doi:10.1161/01.cir.0000124450.07016.1d · Cited by 102
Paraoxonases role in the prevention of cardiovascular diseases
Rosenblat, M., & Aviram, M. (2009) · BioFactors · doi:10.1002/biof.16 · Cited by 102
Laukkanen, M. O., Kivelä, A., Rissanen, T. T., Rutanen, J., Karkkainen, M. K., Leppänen, O., Bräsen, J. H., & Ylä‐Herttuala, S. (2002) · Circulation · doi:10.1161/01.cir.0000031331.05368.9d · Cited by 96
Fennell, J., Brosnan, M. J., Frater, A. J., Hamilton, C., Alexander, M. Y., Nicklin, S. A., Heistad, D. D., Baker, A. H., & Dominiczak, A. F. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301633 · Cited by 95
Li, Q., Park, K., Li, C.-Z., Rask‐Madsen, C., Mima, A., Qi, W., Mizutani, K., Huang, P. L., & King, G. L. (2013) · Circulation Research · doi:10.1161/circresaha.113.301074 · Cited by 93
Schuhmacher, S., Oelze, M. W., Bollmann, F., Kleinert, H., Otto, C., Heeren, T. F. C., Steven, S., Hausding, M., Knorr, M., Pautz, A., et al. (2011) · Diabetes · doi:10.2337/db10-1395 · Cited by 90
Role of Heme Oxygenase-1 in Cardiovascular Function
Perrella, M. A., & Yet, S. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033453776 · Cited by 83
Steinkamp-Fenske, K., Bollinger, L., Xu, H., Yao, Y., Horke, S., Förstermann, U., & Li, H. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123356 · Cited by 82
Targeting Endothelial Dysfunction in Vascular Complications Associated with Diabetes
Sharma, A., Bernatchez, P. N., & de Haan, J. B. (2011) · International Journal of Vascular Medicine · doi:10.1155/2012/750126 · Cited by 81
Ghosh, M., Wang, H. D., & McNeill, J. R. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705557 · Cited by 80
Therapeutic potential of resolvins in the prevention and treatment of inflammatory disorders
Lee, H., & Surh, Y. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.004 · Cited by 80
Velmurugan, G. V., Sundaresan, N. R., Gupta, M. P., & White, C. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt125 · Cited by 79
Steinkamp-Fenske, K., Bollinger, L., Völler, N., Xu, H., Yao, Y., Bauer, R., Förstermann, U., & Li, H. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.028 · Cited by 79
Zhang, Y., Handy, D. E., & Loscalzo, J. (2005) · Circulation Research · doi:10.1161/01.res.0000164401.21929.cf · Cited by 77
Pathogenesis and pathophysiology of accelerated atherosclerosis in the diabetic heart
D’Souza, A., Hussain, M., Howarth, F. C., Woods, N. M., Bidasee, K. R., & Singh, J. (2009) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-009-0148-8 · Cited by 75
Effect of silibinin on endothelial dysfunction and ADMA levels in obese diabetic mice
Volti, G. L., Salomone, S., Sorrenti, V., Mangiameli, A., Urso, V., Siarkos, I., Galvano, F., & Salomone, F. (2011) · Cardiovascular Diabetology · doi:10.1186/1475-2840-10-62 · Cited by 73
Cardiovascular Therapeutics Targets on the NO–sGC–cGMP Signaling Pathway: A Critical Overview
Évora, P. R. B., Évora, P. M., Celotto, A. C., Rodrigues, A. J., & Joviliano, E. É. (2012) · Current Drug Targets · doi:10.2174/138945012802002348 · Cited by 72
Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties
Rozenberg, O., Shiner, M., Aviram, M., & Hayek, T. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.02.012 · Cited by 71
Cheang, W. S., Wong, W. T., Tian, X. Y., Yang, Q., Lee, H. K., He, G., Yao, X., & Huang, Y. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr233 · Cited by 70
Zanetti, M., Sato, J., Katušić, Z. S., & O’Brien, T. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.6.h2516 · Cited by 69
Just, A., Whitten, C. L., & Arendshorst, W. J. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00506.2007 · Cited by 61
Cited by
Pathophysiology of type 2 diabetes mellitus
Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176275 · Cited by 3,360
“AGE binding to the RAGE-receptor, nuclear transcription factor NF-κB [242,243] is activated leading to transcription of endothelin-1, VCAM-1, ICAM-1, E-selectin, thrombomodulin, TF, vascular endothelial growth factor (VEGF), IL-1, IL-6, and TNF-α [242,244].”
BackgroundIncalza, M. A., D'Oria, R., Natalicchio, A., Perrini, S., Laviola, L., & Giorgino, F. (2018) · Vascular Pharmacology · doi:10.1016/j.vph.2017.05.005 · Cited by 1,356
MCP-1: Function, regulation, and involvement in disease
Singh, S., Anshita, D., & Ravichandiran, V. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107598 · Cited by 883
Circular RNA and its mechanisms in disease: From the bench to the clinic
Han, B., Chao, J., & Yao, H. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.01.010 · Cited by 788
González, P., Lozano, P., Ros, G., & Solano, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119352 · Cited by 777
Metadata
- Authors
- Sena, C. M., Pereira, A. M., & Seiça, R.
- Venue
- Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 1832
- Issue
- 12
- Pages
- 2216-2231
- ISSN
- 0925-4439 (ISSN-L)
- OpenAlex
- W2069294586
- Cited by
- 797
- References
- 233
- FWCI
- 30.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.